These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 27461120

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Infantile hemangioma: Efficacy of low-dose propranolol and of intralesional bleomycin injection for propranolol non-response.
    Düzenli Kar Y, Özdemir ZC, Acu B, Bör Ö.
    Pediatr Int; 2019 May; 61(5):459-464. PubMed ID: 30861274
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Management of infantile hemangiomas-experience of a tertiary hospital.
    Gomes R, Salazar L, Fraga C, Correia MR, Barbosa-Sequeira J, Fernandes A, Álvares S, Banquart Leitão J, Paiva Coelho M.
    Eur J Pediatr; 2023 Apr; 182(4):1611-1618. PubMed ID: 36705724
    [Abstract] [Full Text] [Related]

  • 5. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.
    de Graaf M, Breur JMPJ, Raphaël MF, Vos M, Breugem CC, Pasmans SGMA.
    J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Initial experiences with propranolol treatment of infantile hemangiomas: report of three cases.
    Halilbasic A, Hotic N, Husaric E, Rahmanovic E, Halilbasic M, Husaric S.
    Med Arh; 2011 Aug; 65(6):380-2. PubMed ID: 22299307
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Symplastic hemangioma developing over an infantile hemangioma during propranolol treatment.
    Downey C, Pino G, Zambrano MJ, Kramer D, Cervilla K, González S.
    Pediatr Dermatol; 2019 Nov; 36(6):961-962. PubMed ID: 31468563
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase.
    Vivas-Colmenares GV, Bernabeu-Wittel J, Alonso-Arroyo V, Matute de Cardenas JA, Fernandez-Pineda I.
    Pediatr Dermatol; 2015 Nov; 32(3):348-52. PubMed ID: 25721095
    [Abstract] [Full Text] [Related]

  • 17. Infantile Sacral Region Hemangioma and Combination Treatment with Propranolol and Topical Timolol: Case Review and Reference Review.
    Kardasevic M, Dinarevic SM.
    Med Arch; 2021 Apr; 75(2):158-161. PubMed ID: 34219878
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.
    El Hachem M, Gesualdo F, Diociaiuti A, Berti I, Vercellino N, Boccaletti V, Neri I, Porcedda G, Greco A, Carnevale C, Oranges T, Cutrone M, Dalmonte P.
    Ital J Pediatr; 2017 Apr 19; 43(1):40. PubMed ID: 28424095
    [Abstract] [Full Text] [Related]

  • 20. The role of propranolol in the treatment of infantile hemangioma.
    Laranjo S, Costa G, Paramés F, Freitas I, Martins JD, Trigo C, Pinto FF.
    Rev Port Cardiol; 2014 May 19; 33(5):289-95. PubMed ID: 24906291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.